Azathioprine therapy selectively ablates human Vδ2⁺ T cells in Crohn's disease. [electronic resource]
Producer: 20151023Description: 3215-25 p. digitalISSN:- 1558-8238
- Adolescent
- Adult
- Aged
- Azathioprine -- administration & dosage
- Child
- Child, Preschool
- Crohn Disease -- drug therapy
- Female
- Humans
- Immunosuppressive Agents -- administration & dosage
- Intestinal Mucosa -- immunology
- Male
- Middle Aged
- Receptors, Antigen, T-Cell, gamma-delta -- immunology
- Receptors, Retinoic Acid -- immunology
- Retinoic Acid Receptor alpha
- T-Lymphocytes -- immunology
- Tumor Necrosis Factor-alpha -- immunology
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.